Emergent BioSolutions Inc. (EBS)
NYSE · Healthcare
Emergent BioSolutions Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Emergent BioSolutions Inc. shareholder equity for the quarter ending December 31, 2025 were 522.6M, a 8.24% increase year-over-year.
- Emergent BioSolutions Inc. shareholder equity for 2025 were 522.6M, a 8.24% increase from 2024.
- Emergent BioSolutions Inc. shareholder equity for 2024 were 482.8M, a 25.64% decrease from 2023.
- Emergent BioSolutions Inc. shareholder equity for 2023 were 649.3M, a 53.21% decrease from 2022.
- Emergent BioSolutions Inc. shareholder equity for 2022 were 1.39B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Emergent BioSolutions Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $523 |
| 2024 | $483 |
| 2023 | $649 |
| 2022 | $1,388 |
| 2021 | $1,612 |
| 2020 | $1,451 |
| 2019 | $1,091 |
| 2018 | $1,011 |
| 2017 | $912 |
| 2016 | $596 |
| 2015 | $660 |
| 2014 | $553 |
| 2013 | $490 |
| 2012 | $441 |
| 2011 | $414 |
| Emergent BioSolutions Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $523 |
| 2024-12-31 | $483 |
| 2023-12-31 | $649 |
| 2022-12-31 | $1,388 |
| 2021-12-31 | $1,612 |
| 2020-12-31 | $1,451 |
| 2019-12-31 | $1,091 |
| 2018-12-31 | $1,011 |
| 2017-12-31 | $912 |
| 2016-12-31 | $596 |
| 2015-12-31 | $660 |
| 2014-12-31 | $553 |
| 2013-12-31 | $490 |
| 2012-12-31 | $441 |
| 2011-12-31 | $414 |
| 2010-12-31 | $369 |
Emergent BioSolutions Inc. Shareholder Equity — FAQ
Emergent BioSolutions Inc. (EBS) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EBS's shareholder equity history?
The chart and table above show Emergent BioSolutions Inc.'s shareholder equity by year and by quarter, including the growth rate.